Literature DB >> 27187482

(18)F-FDG PET/CT Findings in Acute Epstein-Barr Virus Infection Mimicking Malignant Lymphoma.

Mathilde Ørbæk1, Jesper Graff2, Elena Markova3, Gitte Kronborg4, Anne-Mette Lebech5.   

Abstract

We present a case demonstrating the diagnostic work-up and follow-up of a patient with acute Epstein-Barr virus (EBV) infection in which the clinical picture and imaging on (18)F-FDG PET/CT mimicked malignant lymphoma. Follow-up (18)F-FDG PET/CT scan in the patient performed 7 weeks after the abnormal scan revealed complete resolution of the metabolically active disease in the neck, axillas, lung hili, and spleen. This case highlights inflammation as one of the most well established false positives when interpreting (18)F-FDG PET/CT scans.

Entities:  

Keywords:  18F-FDG PET/CT; Epstein-Barr virus; infectious mononucleosis; lymphadenopathy; malignant lymphoma

Year:  2016        PMID: 27187482      PMCID: PMC4931413          DOI: 10.3390/diagnostics6020018

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


A 21-year-old man presented with 6 weeks of unexplained fever, pharyngitis, enlarged cervical neck lymph nodes, night sweats and severe fatigue. The patient was treated as an outpatient with antibiotics for acute tonsillitis twice without any improvement. He had persistent daily fever and a 6 kg unintentional weight loss. No significant past medical history. Epstein-Barr virus (EBV) and Cytomegalovirus (CMV) titers drawn one week after debut of symptoms were negative. Three months before presenting with symptoms the patient had been travelling in South East Asia for 3.5 months. He had not been sick during his travel abroad. Physical examination was significant for lymphadenopathy at the cervical neck. No splenomegaly was noted. At admission white blood cells was 13.0 × 109/L (normal range: 3.5–8.8 × 109/L) with 10.0 × 109/L lymphocytes (normal range: 1.0–3.5 × 109/L). Alanine aminotransferase (ALT) was elevated at 104 U/L (normal range: 10–70 U/L) and Lactate dehydrogenase (LDH) was elevated at 939 U/L (normal range: 105–205 U/L). Due to concern of malignant lymphoma an 18F-FDG PET/CT was performed (Figure 1). The scan revealed pathologically 18F-FDG uptake in enlarged lymph nodes in the bilateral regions of neck, axillas, lung hili, and in an enlarged spleen (18 cm). Findings were suspicious for malignant lymphoma. A lymph node biopsy was considered.
Figure 1

A 21-year-old man presented with 6 weeks of unexplained fever, pharyngitis, enlarged cervical neck lymph nodes, night sweats and severe fatigue. The patient was treated as an outpatient with antibiotics for acute tonsillitis twice without any improvement. He had persistent daily fever and a 6 kg unintentional weight loss. No significant past medical history. Epstein-Barr virus (EBV) and Cytomegalovirus (CMV) titers drawn one week after debut of symptoms were negative. Three months before presenting with symptoms the patient had been travelling in South East Asia for 3.5 months. He had not been sick during his travel abroad. Physical examination was significant for lymphadenopathy at the cervical neck. No splenomegaly was noted. At admission white blood cells was 13.0 × 109/L (normal range: 3.5–8.8 × 109/L) with 10.0 × 109/L lymphocytes (normal range: 1.0–3.5 × 109/L). Alanine aminotransferase (ALT) was elevated at 104 U/L (normal range: 10–70 U/L) and Lactate dehydrogenase (LDH) was elevated at 939 U/L (normal range: 105–205 U/L). Due to concern of malignant lymphoma an 18F-FDG PET/CT was performed (Figure 1). The scan revealed pathologically 18F-FDG uptake in enlarged lymph nodes in the bilateral regions of neck, axillas, lung hili, and in an enlarged spleen (18 cm). Findings were suspicious for malignant lymphoma. A lymph node biopsy was considered.

Additional diagnostic workup drawn a day prior to the 18F-FDG PET/CT became available showing positive EBV VCA-IgM and negative EBV VCA-IgG indicating acute infectious mononucleosis. CMV-IgM was furthermore positive. HIV and hepatitis panels were negative. Given the patient’s age, the clinical course with no past medical history and acute EBV titers, the patient’s abnormal 18F-FDG PET/CT scan was most likely secondary to acute EBV infection and no lymph node biopsy was performed. The patient was closely monitored. After a week he had resolution of symptoms clinically, ALT had increased to 461 U/L, LDH to 780 U/L. Twenty days after the initial 18F-FDG PET/CT scan the patient was feeling well, he had regained his appetite and returned to daily activities although still complained of tiredness. ALT = 193 U/L, LDH = 295 U/L. At this time both EBV VCA-IgG and EBV VCA-IgM antibodies were positive. CMV IgG was negative and CMV-IgM was borderline indicating a previous false positive CMV-IgM probably induced by the EBV infection. Follow-up 18F-FDG PET/CT scan in the patient performed 7 weeks after the initial scan (Figure 2) revealed complete metabolic response. Except for one lymph node which had decreased in size from 2.0 cm to 1.2 cm, all the other lymph nodes had regressed to normal size on CT. The size of the spleen had normalized (14 cm). ALT and LDH were normal. Reporting of this case is in accordance with the ethical standards of the institutional and/or national research committee. 18F-FDG uptake in EBV infection has been reported previously in a few cases in children [1] and organ transplant recipients [2]. Only two cases of 18F-FDG uptake in acute adult EBV infection have previously been reported [3,4]. In conclusion, this case illustrates acute adult EBV infection in a non-immunocompromised adult with EBV-induced lymphadenopathy that mimicked malignant lymphoma on 18F-FDG PET/CT scan. It highlights inflammation as one of the most well established causes of falsely interpreting 18F-FDG PET/CT as suspicious of malignancy. Any inflammatory process can demonstrate hypermetabolic activity because of the high degree of glucose metabolism by activated cells of inflammation [5,6]. As always, the benefits of 18F-FDG PET/CT in diagnostic work-up should be viewed in light of the radiation burden to the patient.
Figure 2

Additional diagnostic workup drawn a day prior to the 18F-FDG PET/CT became available showing positive EBV VCA-IgM and negative EBV VCA-IgG indicating acute infectious mononucleosis. CMV-IgM was furthermore positive. HIV and hepatitis panels were negative. Given the patient’s age, the clinical course with no past medical history and acute EBV titers, the patient’s abnormal 18F-FDG PET/CT scan was most likely secondary to acute EBV infection and no lymph node biopsy was performed. The patient was closely monitored. After a week he had resolution of symptoms clinically, ALT had increased to 461 U/L, LDH to 780 U/L. Twenty days after the initial 18F-FDG PET/CT scan the patient was feeling well, he had regained his appetite and returned to daily activities although still complained of tiredness. ALT = 193 U/L, LDH = 295 U/L. At this time both EBV VCA-IgG and EBV VCA-IgM antibodies were positive. CMV IgG was negative and CMV-IgM was borderline indicating a previous false positive CMV-IgM probably induced by the EBV infection. Follow-up 18F-FDG PET/CT scan in the patient performed 7 weeks after the initial scan (Figure 2) revealed complete metabolic response. Except for one lymph node which had decreased in size from 2.0 cm to 1.2 cm, all the other lymph nodes had regressed to normal size on CT. The size of the spleen had normalized (14 cm). ALT and LDH were normal. Reporting of this case is in accordance with the ethical standards of the institutional and/or national research committee. 18F-FDG uptake in EBV infection has been reported previously in a few cases in children [1] and organ transplant recipients [2]. Only two cases of 18F-FDG uptake in acute adult EBV infection have previously been reported [3,4]. In conclusion, this case illustrates acute adult EBV infection in a non-immunocompromised adult with EBV-induced lymphadenopathy that mimicked malignant lymphoma on 18F-FDG PET/CT scan. It highlights inflammation as one of the most well established causes of falsely interpreting 18F-FDG PET/CT as suspicious of malignancy. Any inflammatory process can demonstrate hypermetabolic activity because of the high degree of glucose metabolism by activated cells of inflammation [5,6]. As always, the benefits of 18F-FDG PET/CT in diagnostic work-up should be viewed in light of the radiation burden to the patient.

  6 in total

1.  22. FDG Uptake in Infectious Mononucleosis.

Authors: 
Journal:  Clin Positron Imaging       Date:  2000-07

Review 2.  False-positive FDG PET uptake--the role of PET/CT.

Authors:  Sandra J Rosenbaum; Thomas Lind; Gerald Antoch; Andreas Bockisch
Journal:  Eur Radiol       Date:  2005-12-17       Impact factor: 5.315

3.  Lymphadenopathy resulting from acute hepatitis C infection mimicking metastatic breast carcinoma on FDG PET/CT.

Authors:  Heather A Jacene; Vered Stearns; Richard L Wahl
Journal:  Clin Nucl Med       Date:  2006-07       Impact factor: 7.794

4.  Posttransplant lymphoproliferative disorder in a lung transplant recipient.

Authors:  Ken Tamai; Takashi Koyama; Tsuneo Saga; Shigeaki Umeoka; Akihiro Aoyama; Nobuharu Hanaoka; Tatsuo Fukuse; Hiromi Wada; Mitsuhiro Tachibana; Kaori Togashi
Journal:  J Thorac Imaging       Date:  2005-11       Impact factor: 3.000

5.  Epstein-Barr virus mimicking lymphoma on FDG-PET/CT.

Authors:  Damita L Thomas; Sergei Syrbu; Michael M Graham
Journal:  Clin Nucl Med       Date:  2009-12       Impact factor: 7.794

6.  FDG PET/CT findings in acute adult mononucleosis mimicking malignant lymphoma.

Authors:  Maryam B Lustberg; Omer Aras; Barry R Meisenberg
Journal:  Eur J Haematol       Date:  2008-05-06       Impact factor: 2.997

  6 in total
  3 in total

1.  The Role of Pre-therapeutic 18F-FDG PET/CT in Pediatric Hemophagocytic Lymphohistiocytosis With Epstein-Barr Virus Infection.

Authors:  Xia Lu; Ang Wei; Xu Yang; Jun Liu; Siqi Li; Ying Kan; Wei Wang; Tianyou Wang; Rui Zhang; Jigang Yang
Journal:  Front Med (Lausanne)       Date:  2022-01-21

2.  Preclinical evaluation of [18F]FDG-PET as a biomarker of lymphoid tissue disease and inflammation in Zika virus infection.

Authors:  Carla Bianca Luena Victorio; Joanne Ong; Jing Yang Tham; Marie Jennifer Reolo; Wisna Novera; Rasha Msallam; Satoru Watanabe; Shirin Kalimuddin; Jenny G Low; Subhash G Vasudevan; Ann-Marie Chacko
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-07-25       Impact factor: 10.057

3.  Two cases of angioimmunoblastic T-cell lymphoma with concomitant positive serology for acute Epstein-Barr virus infection.

Authors:  Davide Facchinelli; Angela Polino; Francesco Dima; Alice Parisi; Achille Ambrosetti; Dino Veneri
Journal:  Hematol Rep       Date:  2017-09-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.